Impact of Exposure to Diesel Exhaust on Inflammation Markers and Proteases in Former Smokers with Chronic Obstructive Pulmonary Disease: A Randomized, Double-blinded, Crossover Study:

Min Hyung Ryu, Tina Afshar, Hang Li, Denise J. Wooding, Juma Orach, Jin Sheng Zhou, Shane Murphy, Kevin S. K. Lau, Carley Schwartz, Agnes C. Y. Yuen, Christopher F. Rider, and Chris Carlsten

24 February, 2022

NZ Respiratory Research Review Issue 204

Azithromycin for Poorly Controlled Asthma in Children - A Randomized Controlled Trial:

Jagat Jeevan Ghimire, MD Kana Ram Jat, MD Jhuma Sankar, MD Rakesh Lodha, MD Venkat K. Iyer, MD Hitender Gautam, MD Seema Sood, MD S.K. Kabra, MD

21 February, 2022

NZ Respiratory Research Review Issue 200

Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic Use:

David J. Jackson, MRCP, PhD Hassan Burhan, MD Andrew Menzies-Gow, PhD Paul Pfeffer, PhD Alexandra Nanzer, PhD Esther Garcia Gil, MD Tamsin Morris, BSc Trung N. Tran, MD, PhD Ian Hirsch, PhD Sabada Dube, PhD

21 February, 2022

NZ Respiratory Research Review Issue 200

Evaluation of pleural fluid cytology for the diagnosis of malignant pleural effusion: a retrospective cohort study:

Lorna Pairman, Lutz E. L. Beckert, Mark Dagger, Michael J. Maze

21 February, 2022

NZ Respiratory Research Review Issue 205

Association between very to moderate preterm births, lung function deficits, and COPD at age 53 years: analysis of a prospective cohort study:

Dinh S Bui, PhD, Jennifer L Perret, PhD, Prof E Haydn Walters, DM Caroline J Lodge, PhD Gayan Bowatte, PhD Garun S Hamilton, PhD et al.

18 February, 2022

NZ Respiratory Research Review Issue 198

An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study):

Aliasgar Esmail, Suzette Oelofse, Carl Lombard, Rubeshan Perumal, Linda Mbuthini, Akhter Goolam Mahomed, Ebrahim Variava, John Black, Patrick Oluboyo, Nelile Gwentshu, Eric Ngam, Tertius Ackerman, Linde Marais, Lynelle Mottay, Stuart Meier, Anil Pooran, Michele Tomasicchio, Julian Te Riele, Brigitta Derendinger, Norbert Ndjeka, Gary Maartens, Robin Warren, Neil Martinson, and Keertan Dheda

17 February, 2022

NZ Respiratory Research Review Issue 199

Alveolar crystal burden in stone workers with artificial stone silicosis:

Simon H. Apte,Maxine E. Tan,Viviana P. Lutzky,Tharushi A. De Silva,Andreas Fiene,Justin Hundloe,David Deller,Clair Sullivan,Peter T. Bell,Daniel C. Chambers

17 February, 2022

NZ Respiratory Research Review Issue 201

Identifying Higher-Volume Antibiotic Outpatient Prescribers Using Publicly Available Medicare Part D Data — United States, 2019:

Katryna A. Gouin, MPH; Katherine E. Fleming-Dutra, MD; Sharon Tsay, MD; Destani Bizune, MPH; Lauri A. Hicks, DO; Sarah Kabbani, MD

11 February, 2022

NZ Respiratory Research Review Issue 196

The HUNT study: Association of comorbidity clusters with long-term survival and incidence of exacerbation in a population-based Norwegian COPD cohort:

Sigrid Anna Aalberg Vikjord, Ben Michael Brumpton, Xiao-Mei Mai, Solfrid Romundstad, Arnulf Langhammer, Lowie Vanfleteren

10 February, 2022

NZ Respiratory Research Review Issue 198

Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism:

David Jiménez, Carmen Rodríguez, Francisco León, Luis Jara-Palomares, Raquel López-Reyes, Pedro Ruiz-Artacho, Teresa Elías, Remedios Otero, Alberto García-Ortega, Agustina Rivas-Guerrero, Jaime Abelaira, Sonia Jiménez, Alfonso Muriel, Raquel Morillo, Deisy Barrios, Raphael Le Mao, Roger D. Yusen, Behnood Bikdeli, Manuel Monreal, and José Luis Lobo for the IPEP investigators

10 February, 2022

NZ Respiratory Research Review Issue 202